* Guardion Health Sciences Inc GHSI.OQ GHSI.O is
expected
to report results on November 8 (estimated).
* The Houston Texas-based company is expected to report
revenue
of $3.553 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Guardion Health
Sciences
Inc is for a loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Guardion
Health
Sciences Inc is $0.7, above its last closing price of $0.17.
This summary was machine generated November 4 at 19:31 GMT. All
figures in US dollars unless otherwise stated